Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $4.26 $6.56 Thursday, 9th May 2024 ANNX stock ended at $5.10. This is 4.72% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 11.00% from a day low at $4.82 to a day high of $5.35.
90 days $4.26 $8.40
52 weeks $1.57 $8.40

Historical Annexon Inc. prices

Date Open High Low Close Volume
May 09, 2024 $4.86 $5.35 $4.82 $5.10 1 868 899
May 08, 2024 $4.72 $4.93 $4.60 $4.87 1 611 018
May 07, 2024 $4.90 $4.99 $4.70 $4.73 2 334 061
May 06, 2024 $5.03 $5.06 $4.80 $4.81 1 478 766
May 03, 2024 $4.75 $5.06 $4.69 $4.88 2 455 599
May 02, 2024 $4.82 $4.85 $4.58 $4.66 860 258
May 01, 2024 $4.59 $4.85 $4.47 $4.75 2 900 232
Apr 30, 2024 $4.70 $4.75 $4.45 $4.55 1 988 814
Apr 29, 2024 $4.76 $4.90 $4.65 $4.70 1 606 725
Apr 26, 2024 $4.65 $4.79 $4.54 $4.70 1 422 324
Apr 25, 2024 $4.37 $4.83 $4.26 $4.59 1 868 519
Apr 24, 2024 $4.83 $4.85 $4.41 $4.45 3 313 840
Apr 23, 2024 $4.55 $4.69 $4.44 $4.44 801 528
Apr 22, 2024 $4.51 $4.67 $4.38 $4.55 1 102 299
Apr 19, 2024 $4.33 $4.71 $4.28 $4.56 1 154 120
Apr 18, 2024 $4.60 $4.76 $4.38 $4.44 1 394 465
Apr 17, 2024 $5.14 $5.21 $4.58 $4.59 1 935 281
Apr 16, 2024 $5.54 $5.70 $5.11 $5.12 1 342 618
Apr 15, 2024 $5.99 $5.99 $5.46 $5.74 1 288 237
Apr 12, 2024 $5.98 $6.07 $5.86 $5.98 1 282 788
Apr 11, 2024 $6.40 $6.56 $6.00 $6.07 787 425
Apr 10, 2024 $6.07 $6.19 $5.91 $6.17 1 145 894
Apr 09, 2024 $5.92 $6.26 $5.81 $6.23 1 287 783
Apr 08, 2024 $6.11 $6.21 $5.79 $6.05 1 373 696
Apr 05, 2024 $6.29 $6.34 $6.03 $6.19 1 016 454
Click to get the best stock tips daily for free!

About Annexon Inc.

Annexon. Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated neurodegeneration. Its product candidates include ANX005, a monoclonal antibody, which is in Phase II/II... ANNX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT